Insider Transactions Screener
Search for and identify insider purchases or sales of company shares. The screener offers additional information and analysis on the transactions and allows users to set up alerts and receive notifications when new transactions occur.
Ticker | Insider | Transaction Type | Ownership Type | Shares Traded | Value / Price | Filing Date |
---|---|---|---|---|---|---|
RDFN
|
Christopher John Nielsen
Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct | 3,000 Added 11.29% |
$6,750
$2.25 p/Share
|
Dec 18
2020 |
AIV
|
Robert A. Miller
Director |
SELL
Open market or private sale
|
Direct | 20,000 Reduced 23.84% |
$90,400
$4.52 p/Share
|
Dec 18
2020 |
INFN
|
Mark A Wegleitner
Director |
SELL
Open market or private sale
|
Direct | 10,000 Reduced 8.39% |
$110,000
$11.0 p/Share
|
Dec 18
2020 |
MYOV
|
Matthew Lang
General Counsel & Corp. Secy. |
SELL
Open market or private sale
|
Direct | 10,000 Reduced 6.42% |
$258,100
$25.81 p/Share
|
Dec 18
2020 |
MYOV
|
Matthew Lang
General Counsel & Corp. Secy. |
BUY
Exercise of conversion of derivative security
|
Direct | 10,000 Added 6.03% |
$77,800
$7.78 p/Share
|
Dec 18
2020 |
MYOV
|
Ferreira Juan Camilo Arjona
Chief Medical Officer |
SELL
Open market or private sale
|
Direct | 2,000 Reduced 1.45% |
$52,000
$26.0 p/Share
|
Dec 18
2020 |
MYOV
|
Ferreira Juan Camilo Arjona
Chief Medical Officer |
BUY
Exercise of conversion of derivative security
|
Direct | 2,000 Added 1.43% |
$15,560
$7.78 p/Share
|
Dec 18
2020 |
BIGC
|
Jeff Mengoli
Chief Legal Officer/Secretary |
BUY
Exercise of conversion of derivative security
|
Direct | 20,000 Added 15.56% |
$7,800
$0.39 p/Share
|
Dec 18
2020 |
XPEL
|
Richard K. Crumly
Director |
SELL
Open market or private sale
|
Indirect | 20,000 Reduced 4.3% |
$1,049,400
$52.47 p/Share
|
Dec 18
2020 |
PRLB
|
Rainer Gawlick
Director |
SELL
Open market or private sale
|
Direct | 2,000 Reduced 7.62% |
$320,000
$160.0 p/Share
|
Dec 18
2020 |
PRLB
|
Rainer Gawlick
Director |
BUY
Exercise of conversion of derivative security
|
Direct | 2,000 Added 7.08% |
$106,680
$53.34 p/Share
|
Dec 18
2020 |
GDOT
|
Jeffrey Osher
Director |
SELL
Open market or private sale
|
Indirect | 8,880 Reduced 2.02% |
$525,696
$59.2 p/Share
|
Dec 18
2020 |
TLRY
|
Michael Auerbach |
BUY
Other acquisition or disposition
|
Indirect | 17,490 Added 33.53% |
-
|
Dec 18
2020 |
TLRY
|
Michael Auerbach |
SELL
Other acquisition or disposition
|
Indirect | 217,982 Reduced 13.43% |
-
|
Dec 18
2020 |
TLRY
|
Andrew Pucher
Chief Corporate Dev Officer |
SELL
Payment of exercise price or tax liability
|
Direct | 3,303 Reduced 10.76% |
-
|
Dec 18
2020 |
TLRY
|
Andrew Pucher
Chief Corporate Dev Officer |
BUY
Exercise of conversion of derivative security
|
Direct | 7,497 Added 19.63% |
-
|
Dec 18
2020 |
XPER
|
Paul E. Davis
Chief Executive Officer |
SELL
Open market or private sale
|
Direct | 6,396 Reduced 5.07% |
$128,240
$20.05 p/Share
|
Dec 18
2020 |
ONEM
|
Bjorn B Thaler
Chief Financial Officer |
SELL
Open market or private sale
|
Direct | 40,500 Reduced 95.78% |
$1,624,860
$40.12 p/Share
|
Dec 18
2020 |
ONEM
|
Bjorn B Thaler
Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct | 40,500 Added 48.92% |
$321,165
$7.93 p/Share
|
Dec 18
2020 |
TWST
|
Emily M. Leproust
Chief Executive Officer |
SELL
Open market or private sale
|
Direct | 2,000 Reduced 0.44% |
$290,880
$145.44 p/Share
|
Dec 18
2020 |
TTGT
|
Christina Van Houten |
BUY
Grant, award, or other acquisition
|
Direct | 657 Added 7.76% |
$37,528
$57.12 p/Share
|
Dec 18
2020 |
TTGT
|
Bruce Levenson |
BUY
Grant, award, or other acquisition
|
Direct | 841 Added 1.61% |
$48,038
$57.12 p/Share
|
Dec 18
2020 |
TTGT
|
Roger M Marino |
BUY
Grant, award, or other acquisition
|
Direct | 701 Added 17.97% |
$40,041
$57.12 p/Share
|
Dec 18
2020 |
TTGT
|
Robert D Burke |
BUY
Grant, award, or other acquisition
|
Indirect | 850 Added 0.73% |
$48,552
$57.12 p/Share
|
Dec 18
2020 |
MAXR
|
Megan Fitzgerald
SVP, GM Space Solutions |
SELL
Payment of exercise price or tax liability
|
Direct | 233 Reduced 0.44% |
$7,829
$33.6 p/Share
|
Dec 18
2020 |
MAXR
|
Leon Anthony Frazier
EVP & GM Public Sector Intell |
SELL
Payment of exercise price or tax liability
|
Direct | 1,604 Reduced 1.02% |
$53,894
$33.6 p/Share
|
Dec 18
2020 |
MAXR
|
Daniel L Jablonsky
President and CEO |
SELL
Payment of exercise price or tax liability
|
Direct | 1,923 Reduced 0.57% |
$64,613
$33.6 p/Share
|
Dec 18
2020 |
MAXR
|
Iii Jeff Robertson
SVP, Chief Internal Ops Ofc |
SELL
Payment of exercise price or tax liability
|
Direct | 878 Reduced 0.88% |
$29,501
$33.6 p/Share
|
Dec 18
2020 |
MAXR
|
Walter S. Scott
EVP and CTO |
SELL
Payment of exercise price or tax liability
|
Direct | 2,827 Reduced 1.13% |
$94,987
$33.6 p/Share
|
Dec 18
2020 |
SDGR
|
Karen Akinsanya
President of R&D, Therapeutics |
SELL
Open market or private sale
|
Direct | 13,377 Reduced 100.0% |
$1,070,160
$80.0 p/Share
|
Dec 18
2020 |
SDGR
|
Karen Akinsanya
President of R&D, Therapeutics |
BUY
Exercise of conversion of derivative security
|
Direct | 13,377 Added 50.0% |
$43,074
$3.22 p/Share
|
Dec 18
2020 |
SDGR
|
Jenny Herman
SVP & Controller |
SELL
Open market or private sale
|
Direct | 1,217 Reduced 99.75% |
$97,360
$80.0 p/Share
|
Dec 18
2020 |
SDGR
|
Michael Lynton
Director |
SELL
Open market or private sale
|
Direct | 8,333 Reduced 100.0% |
$666,640
$80.0 p/Share
|
Dec 18
2020 |
SDGR
|
Michael Lynton
Director |
BUY
Exercise of conversion of derivative security
|
Direct | 8,333 Added 50.0% |
$36,165
$4.34 p/Share
|
Dec 18
2020 |
UTZ
|
Jason K Giordano
Director |
BUY
Exercise of in-the-money or at-the-money derivatives securities
|
Direct | 154,667 Added 4.03% |
$1,778,670
$11.5 p/Share
|
Dec 18
2020 |
NOVA
|
Salvo John T Santo
Officer |
SELL
Open market or private sale
|
Direct | 17,144 Reduced 62.97% |
$754,336
$44.0 p/Share
|
Dec 18
2020 |
NOVA
|
Salvo John T Santo
Officer |
BUY
Exercise of conversion of derivative security
|
Direct | 17,144 Added 61.08% |
$319,907
$18.66 p/Share
|
Dec 18
2020 |
PD
|
Dan Alexandru Solomon
Director |
SELL
Open market or private sale
|
Direct | 178,000 Reduced 6.11% |
$8,026,020
$45.09 p/Share
|
Dec 18
2020 |
GBDC
|
Lawrence E Golub
Chairman |
BUY
Open market or private purchase
|
Indirect | 2,000 Added 0.1% |
$27,760
$13.88 p/Share
|
Dec 18
2020 |
GBDC
|
David Golub
Chief Executive Officer |
BUY
Open market or private purchase
|
Indirect | 2,000 Added 0.1% |
$27,760
$13.88 p/Share
|
Dec 18
2020 |
CLBK
|
Noel R. Holland
Director |
BUY
Grant, award, or other acquisition
|
Indirect | 107 Added 1.38% |
$1,608
$15.03 p/Share
|
Dec 18
2020 |
CLBK
|
Geri M. Kelly
EVP & HRO |
BUY
Grant, award, or other acquisition
|
Indirect | 37 Added 0.54% |
$556
$15.03 p/Share
|
Dec 18
2020 |
CLBK
|
Thomas J. Kemly
President & CEO |
BUY
Grant, award, or other acquisition
|
Indirect | 203 Added 0.52% |
$3,051
$15.03 p/Share
|
Dec 18
2020 |
CLBK
|
John Klimowich
SEVP & Chief Risk Officer |
BUY
Grant, award, or other acquisition
|
Indirect | 35 Added 1.82% |
$526
$15.03 p/Share
|
Dec 18
2020 |
CLBK
|
Mark S. Krukar
EVP & Chief Credit Officer |
BUY
Grant, award, or other acquisition
|
Indirect | 50 Added 0.81% |
$751
$15.03 p/Share
|
Dec 18
2020 |
CLBK
|
Brian William Murphy
EVP & Operations Officer |
BUY
Grant, award, or other acquisition
|
Indirect | 23 Added 1.68% |
$346
$15.03 p/Share
|
Dec 18
2020 |
CLBK
|
Allyson Katz Schlesinger
SEVP&Head of Consumer Banking |
BUY
Grant, award, or other acquisition
|
Indirect | 46 Added 1.35% |
$691
$15.03 p/Share
|
Dec 18
2020 |
TRIP
|
Kanika Soni
Chief Commercial Officer |
SELL
Payment of exercise price or tax liability
|
Direct | 5,826 Reduced 21.09% |
-
|
Dec 18
2020 |
TRIP
|
Kanika Soni
Chief Commercial Officer |
BUY
Exercise of conversion of derivative security
|
Direct | 16,633 Added 37.58% |
-
|
Dec 18
2020 |
TRIP
|
Ernst 02494 Teunissen
Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct | 18,812 Reduced 36.5% |
$503,221
$26.75 p/Share
|
Dec 18
2020 |